{"type":"doc","content":[{"type":"paragraph","content":[{"type":"text","marks":[{"type":"bold"}],"text":"Themes"}]},{"type":"bulletList","content":[{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Precision Genomic Medicine"}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Precision Digital Health, Cardiovascular Devices and Trials"}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Precision Cancer Care"}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Precision Musculoskeletal Care"}]}]}]},{"type":"paragraph","content":[{"type":"text","text":"The NIHR Barts Biomedical Research Centre (BRC) is part of the National Institute for Health and Care Research (NIHR) and is a delivery partnership of "},{"type":"text","marks":[{"type":"link","attrs":{"href":"https://www.bartshealth.nhs.uk/","target":"_blank","rel":"noopener noreferrer nofollow","class":null}}],"text":"Barts Health NHS Trust"},{"type":"text","text":", "},{"type":"text","marks":[{"type":"link","attrs":{"href":"https://www.qmul.ac.uk/","target":"_blank","rel":"noopener noreferrer nofollow","class":null}}],"text":"Queen Mary University of London"},{"type":"text","text":", "},{"type":"text","marks":[{"type":"link","attrs":{"href":"https://www.sgul.ac.uk/","target":"_blank","rel":"noopener noreferrer nofollow","class":null}}],"text":"City St George’s, University of London"},{"type":"text","text":" and "},{"type":"text","marks":[{"type":"link","attrs":{"href":"https://www.stgeorges.nhs.uk/","target":"_blank","rel":"noopener noreferrer nofollow","class":null}}],"text":"St George’s University Hospitals NHS Foundation Trust"},{"type":"text","text":" hosted by Barts Health NHS Trust."}]},{"type":"paragraph","content":[{"type":"text","text":"The BRC brings ~7.5 million patients together with outstanding science and enables ground-breaking discoveries to be translated into life-saving treatments. By offering every patient the chance to engage in research we maximise the benefit of new diagnoses and therapies for people with rare and common disease."}]}]}
